readthroughSign in
CompanyALLRNasdaqBoston, MA

Allarity Therapeutics

Allarity Therapeutics develops stenoparib, a PARP/tankyrase inhibitor for advanced ovarian cancer in clinical stage.

8-KNov 17Latest SEC filing
Nov 16Latest story